Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/1996
12/05/1996WO1996038467A1 Fragile x related proteins, compositions and methods of making and using the same
12/05/1996WO1996038463A1 Dna sequence and encoded mammary-specific breast cancer protein
12/05/1996WO1996038178A1 Allogeneic and xenogeneic transplantation
12/05/1996WO1996038171A1 Methods of raising antibodies against e.coli of the family cs4-cfa/1
12/05/1996WO1996038164A1 Serum immunoregulatory polypeptides and uses therefor
12/05/1996WO1996034099A3 Genetic sequences and proteins related to alzheimer's disease, and uses therefor
12/05/1996DE19513595C1 Antikörper gegen Herzmuskel-Actin Antibodies against heart muscle actin
12/05/1996CA2741641A1 Antibody specific for a mammaglobin polypeptide
12/05/1996CA2222968A1 Diagnosis of, and vaccination against, a positive stranded rna virus using an isolated, unprocessed polypeptide
12/05/1996CA2222863A1 Serum immunoregulatory polypeptides and uses therefor
12/05/1996CA2222752A1 Human ice homolog
12/05/1996CA2222419A1 A novel form of dipeptidylpeptidase iv (cd26) found in human serum, antibodies thereto, and uses therefor
12/05/1996CA2220955A1 A novel human purinergic p2u receptor
12/05/1996CA2217131A1 Modified cells and methods for inhibiting xenograft rejection
12/04/1996EP0745852A1 Use of functional derivatives of the intercellular adhesion molecule ICAM-1 in anti-viral therapy
12/04/1996EP0745668A2 DNA coding for sulfotransferase
12/04/1996EP0745612A1 Anti-idiotypic antibodies which induce an immune response against epidermal growth factor receptor
12/04/1996EP0745611A1 Interleukin-4 and Interleukin-1beta synergistically induce VCAM-1
12/04/1996EP0745602A1 Quinidine immunoassay and reagents
12/04/1996EP0745136A1 B7-1-specific ligands, and their use for the induction of t cell anergy
12/04/1996EP0745129A1 Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use
12/04/1996EP0745128A1 Hepatitis b virus mutants, reagents and methods for detection
12/04/1996EP0745125A1 Hematopoietic protein and materials and methods for making it
12/04/1996EP0745124A1 Mammalian cell cycle protein
12/04/1996EP0744958A1 Polyclonal antibody libraries
12/04/1996EP0744957A1 Composition and method for preventing and treating inflammation with immunoglobulin a
12/04/1996EP0744956A1 Peptides and methods against diabetes
12/04/1996EP0479920B1 Novel antibodies reactive with human carcinomas
12/03/1996US5581002 Blocking with butyldimethylsilanyl chloride; alkylation; ozonolyzing with sodium hypochlorite; deblocking
12/03/1996US5580968 Useful in diagnosing and following the course of rheumatoid arthitis
12/03/1996US5580962 Purification of activated protein c by ion exchange chromatography to remove serum amyloid p, antibodies and thrombin-inhibitor complex, then inactivating viruses
12/03/1996US5580960 KS-laminin and methods of use
12/03/1996US5580780 Vascular adhesion protein-(VAP-1) and VAP-1-specific antibodies
12/03/1996US5580774 Anticarcinogenic agents
12/03/1996US5580771 Phosphodiesterases catalyze hydrolysis of cyclic nucleotides, and control cellular concentration of cyclic nucleotides
12/03/1996US5580769 Antiviral protein secreted by peripheral blood lymphocytes which inhibits replication of retroviruses including human immunodeficiency virus
12/03/1996US5580756 Ligand which is reactive with the cd28 receptor on t cells
12/03/1996US5580755 Human pluripotent granulocyte colony-stimulating factor
12/03/1996US5580754 Culturing; transformation; transfection; isolation
12/03/1996US5580753 DNA encoding the human cytokine, interleukin-9
12/03/1996US5580748 Measuring the presence or absence of a particular potassium channel; assessing the effect of poassium channel blockers on intracellular calcium levels; and, measuring activated intracellular calcium release
12/03/1996US5580740 Antihuman pulmonary adenocarcinoma monoclonal antibody
12/03/1996US5580738 Delta-like gene expressed in neuroendocrine tumors
12/03/1996US5580736 Having a cell with a reporter gene linked to a dna sequence comprising a protein binding site, a first and second fusiongene; interacting the binding proteins expressed; measuringthe expression of the reporter gene
12/03/1996US5580723 Comparing the activities of a segment-substituted polypeptide and the parent polypeptide; borrowing receptor binding properties from functionally divergent hormones
12/03/1996US5580717 Recombinant library screening methods
12/03/1996US5580561 Methods and pharmaceutical compositions for blocking suppression of immune defense mechanisms using an antibody, a factor, or an antisense peptide
12/03/1996CA1338771C Adhesion receptor for laminin and its use
12/03/1996CA1338770C Vinyl substituted radiohalogen conjugates for protein labeling
12/01/1996CA2176417A1 Quinidine immunoassay and reagents
11/1996
11/28/1996WO1996037782A1 Method for potentiating tissue plasminogen activators
11/28/1996WO1996037780A1 Compositions and methods for detecting schizophrenia
11/28/1996WO1996037621A2 Multimeric proteins
11/28/1996WO1996037611A1 Eb1 gene product binds to apc
11/28/1996WO1996037606A1 Compositions and methods for the diagnosis of, and vaccination against, hepatitis c virus (hcv)
11/28/1996WO1996037602A1 Porcine hepatocytes for use in treatment of disorders characterized by insufficient liver function
11/28/1996WO1996037516A1 Methods of treatment and diagnostic visualisation, particularly in cancer
11/28/1996WO1996037508A1 Protegrins
11/28/1996WO1996037234A1 Intracellular immunization
11/28/1996WO1996037225A1 Method for treatment of sle
11/28/1996WO1996037224A1 Methods of treating colon cancer utilizing tumor-specific antibodies
11/28/1996WO1996037221A1 Subunit vaccine against flavivirus infection
11/28/1996WO1996037218A1 Parasitic helminth venom allergen antigen 5-like genes and proteins
11/28/1996WO1996037211A1 Latent transcripts and promoters of cytomegalovirus
11/28/1996WO1996029413A3 Dna encoding human papilloma virus type 18
11/28/1996WO1996021734A3 P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods
11/28/1996CA2222475A1 Protegrins
11/28/1996CA2222055A1 Multimeric proteins
11/28/1996CA2221935A1 Method of treating colon cancer utilizing tumor-specific antibodies
11/28/1996CA2221818A1 Parasitic helminth venom allergen antigen 5-like genes and proteins
11/28/1996CA2221383A1 Method for potentiating tissue plasminogen activators
11/28/1996CA2221159A1 Eb1 gene product binds to apc
11/28/1996CA2220415A1 Latent transcripts and promoters of cytomegalovirus
11/28/1996CA2220007A1 Porcine hepatocytes for use in treatment of disorders characterized by insufficient liver function
11/28/1996CA2219479A1 Methods of treatment and diagnostic visualisation, particularly in cancer
11/27/1996EP0743983A1 Mammalian thymokine genes
11/27/1996EP0743958A1 Non-viral vector
11/27/1996EP0743956A1 Pretargeting methods and compounds
11/27/1996EP0743870A1 Preparation and application of artificial anti-idiotypic imprints
11/27/1996EP0743856A1 Antigen-based heteropolymers and method for treating autoimmune diseases using the same
11/27/1996EP0495878B1 Method for purifying chelator conjugated compounds
11/27/1996EP0491867B1 Hybridoma ct43 producing a monoclonal antibody to a mucin epitope of colorectal cancer
11/27/1996EP0446361B1 Polypeptide, production thereof, and pharmaceutical composition and cosmetic containing said polypeptide
11/27/1996CN1136778A Sperm antigen corresponding to sperm zone binding protein autoantigenic epitope
11/27/1996CA2177328A1 Anti-idiotypic antibodies which induce an immune response against epidermal growth factor receptor
11/26/1996US5579250 Computer-assisted method
11/26/1996US5578714 DNA encoding Duffy 9pd protein
11/26/1996US5578708 Derived from bones of mammals including mice and humans; diagnosis and therapy for bone metabolic diseases
11/26/1996US5578707 Soluble interferon-gamma receptor fragment
11/26/1996US5578706 Methods and compositions concerning homogenous immunotoxin preparations
11/26/1996US5578704 Bone disorders
11/26/1996US5578703 Dimer proteins which bind to transforming growth factor
11/26/1996US5578569 Method of increasing bone growth
11/26/1996US5578500 Reagents and methods for the quantification of imipramine or desipramine in biological fluids
11/26/1996US5578484 For detection of prostate cancer
11/26/1996US5578482 Ligand growth factors that bind to the erbB-2 receptor protein and induce cellular responses
11/26/1996US5578453 Cloning and expression of toxoplasma antigens and use of recombinant antigens
11/26/1996US5578448 Polymerase chain reaction
11/26/1996US5578323 Proteinoid carriers and methods for preparation and use thereof
11/26/1996US5578309 For the treatment of candidiasis